Stoke Therapeutics, Inc. (STOK)
30.05
+0.24
(+0.81%)
USD |
NASDAQ |
Sep 08, 16:00
29.60
-0.45
(-1.50%)
After-Hours: 07:28
Stoke Therapeutics Price to Book Value : 5.427 for Sept. 8, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 5.427 |
| September 04, 2026 | 5.383 |
| September 03, 2026 | 5.416 |
| September 02, 2026 | 5.508 |
| September 01, 2026 | 5.578 |
| August 31, 2026 | 5.634 |
| August 28, 2026 | 5.710 |
| August 27, 2026 | 5.886 |
| August 26, 2026 | 5.976 |
| August 25, 2026 | 6.043 |
| August 24, 2026 | 5.837 |
| August 21, 2026 | 5.831 |
| August 20, 2026 | 5.671 |
| August 19, 2026 | 5.965 |
| August 18, 2026 | 5.804 |
| August 17, 2026 | 5.802 |
| August 14, 2026 | 5.647 |
| August 13, 2026 | 5.654 |
| August 12, 2026 | 5.954 |
| August 11, 2026 | 5.952 |
| August 10, 2026 | 5.820 |
| August 07, 2026 | 5.907 |
| August 06, 2026 | 5.766 |
| August 05, 2026 | 5.766 |
| August 04, 2026 | 5.719 |
| Date | Value |
|---|---|
| August 03, 2026 | 5.338 |
| July 31, 2026 | 5.212 |
| July 30, 2026 | 5.425 |
| July 29, 2026 | 5.324 |
| July 28, 2026 | 5.308 |
| July 27, 2026 | 5.293 |
| July 24, 2026 | 5.291 |
| July 23, 2026 | 5.354 |
| July 22, 2026 | 5.230 |
| July 21, 2026 | 5.203 |
| July 20, 2026 | 4.999 |
| July 17, 2026 | 5.246 |
| July 16, 2026 | 5.257 |
| July 15, 2026 | 5.402 |
| July 14, 2026 | 5.261 |
| July 13, 2026 | 5.320 |
| July 10, 2026 | 5.667 |
| July 09, 2026 | 5.929 |
| July 08, 2026 | 5.896 |
| July 07, 2026 | 5.963 |
| July 06, 2026 | 5.857 |
| July 02, 2026 | 5.905 |
| July 01, 2026 | 5.907 |
| June 30, 2026 | 5.909 |
| June 29, 2026 | 5.105 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Biogen, Inc. | 1.665 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.19 |
| Anika Therapeutics, Inc. | 2.051 |
| BioCryst Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 67.01 |
| Price | 30.05 |
| Earnings Yield | -11.22% |
| Market Cap | 1.875B |